Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer’’s disease and other dementias

By Abraham Jean-Daniel   Calvayrac-Pawlowski Sophie   Cobo Sandra   Salvetat Nicolas   Vicat Guillaume   Molina Laurence   Touchon Jacques   Michel Bernard-Franççois   Molina Franck   Verdier Jean-Michel   Fareh Jeannette   Mourton-Gilles Chantal  

Biomarkers, Vol. 16, Iss. 2, 2011-03 ,pp. : 161-171

Informa Healthcare

Access to resources Recommend Favorite

Mechanisms of the Effects of Crocin on Aggregation and Deposition of Aβ1-40 Fibrils in Alzheimer's Disease

By Ghahghaei Arezou  

International Journal of Peptide Research and Therapeutics, Vol. 18, Iss. 4, 2012-12 ,pp. : 347-351

Springer Publishing Company

Access to resources Recommend Favorite

High Levels of Circulating Aβ42 Are Sequestered by Plasma Proteins in Alzheimer's Disease

By Kuo Y-M.   Emmerling M.R.   Lampert H.C.   Hempelman S.R.   Kokjohn T.A.   Woods A.S.   Cotter R.J.   Roher A.E.  

Biochemical and Biophysical Research Communications, Vol. 257, Iss. 3, 1999-04 ,pp. : 787-791

Elsevier

Access to resources Recommend Favorite

Dendritic Spine Loss and Synaptic Alterations in Alzheimer's Disease

By Knobloch Marlen  

Molecular Neurobiology, Vol. 37, Iss. 1, 2008-02 ,pp. : 73-82

Humana Press, Inc

Access to resources Recommend Favorite

CSF total tau, Aβ42 and phosphorylated tau protein as biomarkers for Alzheimer’s disease

By Blennow Kaj   Vanmechelen Eugeen   Hampel Harald  

Molecular Neurobiology, Vol. 24, Iss. 1-3, 2001-08 ,pp. : 87-97

Humana Press, Inc

Access to resources Recommend Favorite